Histogenics' Seed VC Round

Histogenics raised a round of funding on January 13, 2006. Investors include Boston Millennia Partners.

Histogenics is a regenerative medicine company that combines cell therapy and tissue engineering technologies to develop products for tissue repair and regeneration. Histogenics' flagship product…

Articles about Histogenics' Seed VC Round: